CMHC Spring 2021 On Demand
This 2021 CMHC Spring On Demand activity will highlight the latest updates in hypertension, heart failure, diabetes, dyslipidemia, lifestyle management, cardiovascular health, as well as the impacts of COVID-19 on cardiometabolic health, and translate the latest cutting-edge medical research into practical, clinical strategies for preventing, delaying, and managing cardiovascular and metabolic disorders.
To view recordings from PME Symposia, please visit the PME Library located here.
US-based healthcare professionals, including cardiologists, endocrinologists, lipidologists, primary care clinicians (PCPs), registered nurses, advanced practice registered nurses, dieticians, pharmacists, and other allied health professionals.
After completing this activity, the participant should be better able to:
- Discuss the interrelationships among cardiometabolic risk factors and their impact on the development of cardiometabolic diseases, including diabetes, dyslipidemia, hypertension, obesity, kidney disease, and cardiovascular disease.
- Interpret the latest evidence and guidelines for the prevention, screening, and treatment of the complex patient with cardiometabolic risk or cardiometabolic disease.
- Outline strategies aimed at timely screening and prevention of cardiometabolic disease, including biomarkers, imaging, genetic risk assessment, and lifestyle modifications.
- Develop individualized treatment regimens for patients with cardiometabolic disease based on the efficacy and safety of current and new pharmacotherapies, patient comorbidities and preferences to optimize outcomes.
- Review therapy for chronic cardiometabolic diseases, including diabetes, CVD, and obesity in the COVID-19 era, as well as incorporate technology and telemedicine when appropriate to ensure the continuum of care for these patients
Robert H. Eckel, MD (Chair)
Christie M. Ballantyne, MD (Chair)
George L. Bakris, MD (Chair)
Anne L. Peters, MD (Chair)
Deepak L. Bhatt, MD
Joseph A. Aloi, MD
Nicholas B. Argento, MD, FACE
Vanita R. Aroda, MD
Louis J. Aronne, MD
Matthew J. Budoff, MD
Barto Burguera, MD, PhD
Sarah E. Chuzi, MD
Brendan M. Everett, MD, MPH
Sarah Hallberg, DO, MS, ACSM-CEP, FOMA, FNLA
Elaine M. Hylek, MD, MPH
Penny Kris-Etherton, PhD
Carl J. Lavie Jr., MD
Alanna A. Morris, MD, MSc
Pamela B. Morris, MD
Margo Minissian, PhD, ACNP
Aldo J. Peixoto, MD
Ileana L. Piña, MD, MPH, FAHA, FACC
Jane Reusch, MD
Donna H. Ryan, MD
Viral N. Shah, MD
Daichi Shimbo, MD
Jay H. Shubrook, DO, FACOFP, FAAFP
Ahmed M. Soliman, MD
Joseph Vassalotti, MD
Kim A. Williams, Sr., MD
Stephen D. Wiviott, MD, FACC
William F. Young, Jr., MD, MSc
ESTIMATED TIME TO COMPLETE ACTIVITY
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Tarsus Cardio Inc. dba Cardiometabolic Health Congress (CMHC). Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CONTINUING MEDICAL EDUCATION
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 14.75 AMA PRA Category 1 Credits™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.
CONTINUING NURSING EDUCATION
The maximum number of hours awarded for this Continuing Nursing Education activity is 14.75 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate.
CONTINUING PHARMACY EDUCATION
Postgraduate Institute for Medicine designates this continuing education activity for 14.75 contact hour(s) (1.475 CEUs) of the Accreditation Council for Pharmacy Education.
This is an application-based activity. Universal Activity Numbers (UAN): # JA4008162-9999-21-2768-H01-P.
For Pharmacists: Upon completing the post-test and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 – 6 weeks.
CONTINUING DIETICIAN EDUCATION
This program offers 14.75 CPEUs for dieticians.
ABIM MOC CERTIFICATION
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 14.75 MOC points in the American Board of Internal Medicine's (ABIM) maintenance of certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
A full listing of faculty disclosures can be downloaded here.
Planners and Managers
The PIM planners and managers have nothing to disclose. The CMHC planners and managers have nothing to disclose.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
METHOD OF PARTICIPATION & REQUEST FOR CREDIT
There are no registration fees for this activity. During the period May 11, 2021 through May 11, 2022, participants must read the learning objectives and faculty disclosures, study the educational activity, and complete the evaluation. Upon completing, your certificate will be available for print. For questions about receiving certificates, please contact us at CMHC_Eval@cardiometabolichealth.org.
For questions about the accreditation of this activity, please visit www.pimed.com.
For Pharmacists: Please complete the evaluation instructions above. Upon registering and completing the activity evaluation, your transcript information will be sent to the NABP CPE Monitor Service within 4-6 weeks.
- 14.75 ACPE Pharmacy
- 14.75 AMA PRA Category 1 Credit™
- 14.75 ANCC
- 14.75 CDE
- 14.75 Participation
There are no registration fees for this activity. Please enroll and proceed with the course instructions.
A computer with an internet connection
Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.